Addus HomeCare Cor1
docx
keyboard_arrow_up
School
Kenyatta University *
*We aren’t endorsed by this school
Course
EET 301
Subject
Finance
Date
Nov 24, 2024
Type
docx
Pages
10
Uploaded by writerfrancis
Addus HomeCare Corp
Ratio
2022
2021
Working capital
91,661,000
205,442,000
Current ratio
1.698923337
2.727869873
Debt ratio
0.140482775
0.239464534
Earnings per share
2.84438539
2.830991217
Price/earnings ratio
30.11929825
32.58188153
Total asset turnover ratio
1.013993693
0.912318156
Financial leverage
1.480560028
1.649856184
Net profit margin
0.048390319
0.052199019
Return on assets
0.049067478
0.047622113
Return on equity
0.072647347
0.078569638
Option Care Health Inc
Ratio
2022
2021
Working capital
428,988,000
250,561,000
Current ratio
1.758799401
1.545059224
Debt ratio
0.341865043
0.381917348
Earnings per share
827.423086
777.53113
Price/earnings ratio
36.25301205
36.46153846
Total asset turnover ratio
1.267207228
1.23208206
Financial leverage
2.245818673
2.373459672
Net profit margin
0.038166315
0.040684108
Return on assets
0.048364631
0.050126159
Return on equity
0.000108618
0.118972417
The Bancorp Inc
Ratio
2022
2021
Working capital
605,636,000
959,582,000
Current ratio
1.553961375
2.604891029
Debt ratio
0.140817285
0.161561506
Earnings per share
2.338191276
1.928741749
Price/earnings ratio
12.14782609
16.2642487
Total asset turnover ratio
0.050300392
0.046122165
Financial leverage
11.38709942
10.48846202
Net profit margin
0.327560097
0.350583762
Return on assets
0.016476401
0.016169682
Return on equity
0.187618421
0.169595098
Fiscal Year Comparison
Addus HomeCare Corp
Addus HomeCare Corp's financial ratios reveal notable differences between the most recent fiscal year (2022) and the preceding year (2021), providing insights into the company's
evolving financial landscape. Firstly, there is a positive shift in liquidity as evidenced by the current ratio, which increased from 1.6792 in 2021 to 1.6989 in 2022. This improvement signifies a strengthened capacity to meet short-term obligations with current assets, indicating
enhanced financial flexibility.
Operational efficiency also witnessed positive momentum, with the total asset turnover ratio rising from 0.9482 in 2021 to 1.0139 in 2022. This suggests an improved ability to generate revenue from the company's assets, reflecting enhanced operational effectiveness and potentially more efficient utilization of resources.
Financial leverage and debt management portray a strategic shift. The financial leverage ratio decreased, indicating a reduction in reliance on debt for financing. Simultaneously, the debt ratio decreased, reflecting a healthier balance between debt and total
assets. These changes suggest a prudent financial approach, focusing on minimizing financial
risk and reinforcing the company's long-term stability.
While profitability metrics present a mixed picture, with a slight decline in the net profit margin from 5.22% in 2021 to 4.84% in 2022, the increase in earnings per share (EPS) from $2.81 to $2.84 indicates improved profitability on a per-share basis. However, the nuanced decrease in the price-earnings ratio (P/E ratio) suggests potential market considerations around the company's valuation relative to earnings. This calls for a nuanced analysis of factors influencing profitability and market sentiment.
In summary, Addus HomeCare Corp's financial ratios depict a positive trajectory in liquidity, operational efficiency, and financial prudence. The strategic reduction in debt reliance contributes to long-term stability. However, challenges in sustaining net profit margins warrant further examination. The nuanced interplay of these financial indicators
provides a comprehensive understanding of the company's financial health, offering valuable insights for strategic decision-making and future planning.
Option Care Health Inc
Working capital and liquidity improved significantly for Option Care Health Inc in 2022 compared to 2021. Working capital rose 71% from $250.6 million in 2021 to $429.0 million in 2022. This indicates Option Care Health Inc had substantially more current assets available to cover current liabilities last year. Additionally, the current ratio strengthened from
1.55 in 2021 to 1.76 in 2022, signaling enhanced liquidity.
Option Care Health Inc also reduced reliance on debt financing in 2022 versus 2021. The debt ratio decreased from 0.382 to 0.342 over the two year period. This demonstrates that
Option Care Health Inc lowered its leverage and dependence on debt funding.
Profitability metrics were mixed for Option Care Health Inc between 2021 and 2022. On the positive side, earnings per share climbed 19% from $1.93 to $2.30 over the two years.
Total revenue also grew a sizable 26% from $315.6 million in 2021 to $397.5 million in 2022, driven by expansions in both interest income and non-interest income. However, return
on equity dropped precipitously from 11.9% in 2021 to just 0.1% in 2022. Return on assets also slipped slightly from 5.0% to 4.8% over the same period. This indicates that while overall profit levels grew, profit generation relative to shareholder equity and asset utilization declined year-over-year.
In summary, Option Care Health Inc strengthened its financial position and performance in some key areas like working capital, liquidity and revenue growth between 2021 and 2022. But profitability relative to equity and assets worsened over the period. On balance, Option Care Health Inc enhanced its financial profile through improved liquidity, lower debt reliance and earnings growth, though returns were mixed.
The Bancorp Inc
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Working capital and liquidity position declined for The Bancorp in 2022 versus 2021. Working capital decreased substantially from $959.6 million in 2021 to $605.6 million in 2022, a reduction of 37%. Likewise, the current ratio dropped sharply from 2.60 in 2021 to 1.55 in 2022, indicating weakened liquidity. The Bancorp had less current assets available relative to current liabilities at the end of 2022 compared to the prior year.
However, The Bancorp improved its debt profile and leverage between 2021 and 2022. The debt ratio fell from 0.162 in 2021 to 0.141 in 2022, showing reduced dependence on debt financing. Financial leverage also decreased from 10.5 in 2021 to 11.4 in 2022, again demonstrating that The Bancorp lowered its reliance on debt funding year-over-year. In terms of profitability, The Bancorp delivered mixed results over the two year period. On one hand, earnings per share grew 21% from $1.93 in 2021 to $2.34 in 2022, reflecting improved bottom line profitability. Return on equity also rose from 17.0% to 18.8%
over the same timeframe, indicating stronger profit generation relative to shareholder equity. On the other hand, net profit margin declined from 35.1% in 2021 to 32.8% in 2022. Return on assets held steady at around 1.6% in both periods, suggesting flat asset utilization for profitability.
To summarize, while The Bancorp weakened its working capital and liquidity positions from 2021 to 2022, it did make progress reducing leverage and reliance on debt financing. Profit trends were mixed, with EPS and return on equity rising but net margins and
return on assets flat or down slightly year-over-year. On balance, The Bancorp's financial performance was stable, with some metrics improving while others declined.
Comparison Analysis
In evaluating Addus HomeCare Corp's financial health through the lens of calculated financial ratios, discernible trends emerge between the most recent fiscal year (2022) and the preceding year (2021). Notably, the improvement in the current ratio from 1.6792 to 1.6989
indicates a strengthened ability to cover short-term liabilities with current assets. This signifies a healthier liquidity position, suggesting the business is better positioned to meet its immediate financial obligations. Concurrently, the rise in total asset turnover ratio from 0.9482 to 1.0139 reflects enhanced efficiency in utilizing assets to generate revenue, showcasing improved operational performance and resource utilization.
Furthermore, the strategic reduction in financial leverage and debt ratio underscores the company's efforts to mitigate financial risk. With a decreased reliance on debt financing, Addus HomeCare Corp exhibits a more conservative financial structure, contributing to increased financial stability. However, the marginal decline in the net profit margin from 5.22% to 4.84% warrants further exploration into the underlying factors influencing profitability. Understanding the nuances of changes in operating expenses, market dynamics, or competitive pressures is crucial for a comprehensive assessment of the business's financial well-being.
Earnings metrics, including an increase in earnings per share (EPS) from $2.81 to $2.84, signify improved profitability on a per-share basis. Nonetheless, the slight decrease in the price-earnings ratio (P/E ratio) may suggest a nuanced market response, indicating potential considerations around the company's valuation relative to earnings. The uptick in return on assets (ROA) and return on equity (ROE) suggests improved efficiency in generating profit from both assets and shareholders' equity. However, the decrease in ROE indicates a potential challenge in maintaining profitability relative to shareholders' equity, necessitating a deeper exploration of the underlying causes.
Option Care Health
Option Care Health displays positive signs of financial health, particularly in terms of liquidity and debt management. The company grew its working capital substantially from $250.6 million in 2021 to $428.9 million in 2022, a 71% increase. This indicates greater
capacity to fund near-term obligations. Reinforcing this, the current ratio rose from 1.54 in 2021 to 1.76 in 2022, showing strengthened liquidity. Additionally, Option Care Health reduced reliance on leverage, with the debt ratio declining from 0.382 to 0.342 over the two years. Lower financial leverage provides more flexibility and stability. Overall, improving working capital, current ratio, and declining debt dependency demonstrate Option Care Health has enhanced its financial foundation.
Profitability and efficiency metrics for Option Care Health are reasonably steady, with
a few concerns. On the positive side, earnings per share grew a steady 7% from 2021 to 2022,
from $777.53 to $827.42. This reflects consistent bottom-line profit generation. However, net
profit margin slipped slightly from 4.1% to 3.8% over the same period, suggesting some challenges with cost management impacting profit per dollar of revenue. Return on assets also dropped marginally from 5.0% to 4.8%, indicating somewhat weaker asset utilization for
driving profits. But these declines are relatively minor. The high 36x price-to-earnings ratio also implies the market sees growth opportunities ahead.
The most worrisome profitability metric for Option Care Health is the plunge in return on equity from 11.9% in 2021 to just 0.01% in 2022. This sharp reduction in profitability relative to shareholder equity warrants further diagnosis. Potential factors could include one-time charges depressing net income, issuing significant new equity, or subpar capital management. More details would be needed to pinpoint the drivers of this downward trend. But the equity returns face clear challenges.
In summary, Option Care Health shows largely positive signs of financial health from its improving liquidity, debt reduction, and steady earnings per share. Minor concerns exist around cost management and asset efficiency. However, the dramatic drop in return on equity
due to unknown factors merits further analysis to determine why capital profitability has
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
deteriorated. With some targeted diagnostics, Option Care Health seems positioned for overall financial stability and success. But optimizing equity returns is a top priority.
The Bancorp Inc
The Bancorp displays some signs of weakened short-term financial health but improved long-term stability between 2021 and 2022. Working capital dropped substantially from $959.6 million to $605.6 million over the two years, concerning for liquidity to cover near-term obligations. Reinforcing this, the current ratio declined sharply from 2.60 to 1.55, well below the 2.0 rule-of-thumb for adequate liquidity. The Bancorp's capacity to handle short-term demands has clearly been reduced. However, the debt ratio fell from 0.162 to 0.141, showing The Bancorp has lessened dependence on leverage and improved long-term stability. But near-term liquidity management is a challenge.
Profitability presents a mixed picture for The Bancorp. On the positive side, earnings per share grew a solid 21% between 2021 and 2022, from $1.93 to $2.34, demonstrating strong bottom-line profit generation. Return on equity also improved slightly from 17.0% to 18.8%, indicating marginally better capital efficiency. However, net profit margin declined from 35.1% to 32.8% over the two years. This suggests revenue growth is not keeping pace with expenses, pressuring profit per dollar earned. Flat return on assets of 1.6% also implies challenges with using assets to drive profits.
The decline in The Bancorp's price-to-earnings ratio from 16.3x to 12.1x implies the market sees some challenges in maintaining strong earnings growth. While profits are up, investors appear concerned about sustainability. Overall profitability is mixed, with EPS gains but weaker margins and returns on assets and equity. There are positive signs but also clear concerns on the profit front.
In summary, The Bancorp's financial health shows some short-term vulnerabilities from declining working capital and liquidity but improved long-term stability from lower
leverage. Profitability is mixed with EPS gains but weaker efficiency in generating profits from revenue, assets and equity. More information on the drivers and projections for working capital, liquidity management, and profitability could clarify The Bancorp's ability to maintain stable financial health. But the current situation appears relatively balanced between
progress and challenges.
Short-Term Financing
Addus HomeCare Corp, as reflected in its current financial information, possesses various potential short-term financing sources that can play a pivotal role in augmenting its financial health. Firstly, the existing revolving credit facility provides the company with flexibility in accessing funds as needed. With $134,853,000 available at the end of 2022, the revolving credit line allows Addus HomeCare to manage short-term cash needs, supporting working capital requirements or immediate financial demands. This source enables the business to maintain agility and responsiveness to fluctuations in cash flow.
Additionally, the business's term loan under the credit facility serves as another short-
term financing avenue. While there is no outstanding balance specified for the current year, the availability of this term loan provides a potential mechanism for Addus HomeCare to secure short-term funds for specific projects or operational needs. This flexibility allows the business to align its financing strategy with the evolving requirements of its operations. By leveraging these credit facilities judiciously, the company can bridge short-term funding gaps and enhance its overall financial resilience.
Moreover, exploring accounts receivable financing can be instrumental in bolstering short-term liquidity. With accounts receivable totaling $125,501,000 at the end of 2022, the business can consider factoring or receivables-based financing, allowing it to swiftly convert outstanding receivables into immediate cash. This approach not only accelerates cash inflows but also improves working capital efficiency, supporting the company's ability to meet short-
term financial obligations and invest in growth opportunities. In summary, a strategic combination of these short-term financing sources, including credit facilities and receivables financing, provides Addus HomeCare Corp with the means to address immediate financial needs, optimize liquidity, and navigate dynamic business conditions effectively.
Option Care Health
With working capital declining by 41% and the current ratio dropping from 1.75 to 1.54 between 2021 and 2022, Option Care Health needs an infusion of short-term funding to restore financial flexibility. This will enable Option Care Health to meet near-term obligations, invest in growth, and improve its liquidity position. Select financing sources that provide quick cash while maintaining the recent debt reduction progress must be pursued.
Working capital loans from commercial banks are one option to inject funding without high costs or diluting shareholders. These loans use accounts receivable, inventories, and other working capital assets as collateral while providing cash for operations and expansion. Given Option Care Health's size, major banks should have appetite for a structured working capital lending facility. It infuses cash while leveraging the current asset base.
Factoring receivables is another fast financing source for Option Care Health. Rather than waiting 30-90 days for customer invoices to be paid, selling the receivables to a factor immediately generates cash, minus a small discount fee. Healthcare billing cycles can be lengthy, so factoring converts receivables into instant liquidity. This can help fund growth in the near-term as revenue ramps up.
Since Option Care Health provides extensive healthcare services, equipment leasing also warrants consideration. Financing companies can lease specialized clinical machinery and devices to Option Care Health rather than requiring large upfront capex. This preserves
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
capital while still gaining access to essential healthcare equipment. As revenue grows, owned-equipment purchases can increase.
Finally, expanding existing bank credit lines, if available, could be a cost-effective financing option. Option Care Health improved its debt profile from 2021 to 2022. If current lenders see this progress, higher credit limits may be supported, enabling more short-term borrowing under favorable bank terms. This efficiently leverages strengthened borrower metrics.
A thoughtful mix of working capital loans, factoring, leasing, and expanded debt facilities can give Option Care Health the firepower to drive growth in the near-term while retaining its improved leverage position. The goal is quickly and cost-effectively bridging the
gap until operating cash flows catch up with expanding business needs. With several tailored short-term financing sources, Option Care Health can restore depleted liquidity and working capital.
Related Questions
Compute NET Profit margin ratio
arrow_forward
provide reasons for the attached calculated ratios using GSK 2023 annual report and provide non-financail performance analysis examples for GSK 2023.
arrow_forward
Calculate gross profit ratio for the year 2018 and 2019
arrow_forward
B.
Working Capital
=
Current Assets - Current Liabilities
2021
=
Working Capital
$263,000 - $50,000 $213,000
2022
Working Capital =
$347,000 $69,000 = $278,000
Current Ratio =
Current Assets
Current Liabilities
2021
2022
Current Ratio
=
$263,000
$50,000
$347,000
$69,000
=
5.3:1
5.0:1
Debt to Total Assets
= Total Liabilities
Total Assets
2021
2022
=
$180,000
$382,000
$184,000
$487,000
=
47.1%
37.8%
C.
The working capital has increased between 2021 and 2022, indicating greater liquidity for the firm in its ability to pay its current liabilities as they become due. The current ratio has
decreased between 2021 and 2022; however, it is still quite high. Note also that there is a substantial portion of the current assets in cash and accounts receivable, which may be
converted into cash quickly (assuming the receivables are collectible). The company, therefore, should not have any problems in paying its current liabilities as they become due.
The debt to total assets indicates the percentage…
arrow_forward
Consolidated Statements of Operations
FINANCIAL STATEMENTS
Table of Contents
Index to Financial Statements
(millions, except per share data)
2020
2019
2018
Sales
Other revenue
$
92,400 $
77,130 $
74,433
1,161
982
923
Total revenue
93,561
78,112
75,356
Cost of sales
66,177
54,864
53,299
Selling, general and administrative expenses
18,615
16,233
15,723
Depreciation and amortization (exclusive of depreciation included in cost
of sales)
2,230
2,357
2,224
Operating income
6,539
4,658
4,110
Net interest expense
977
477
461
Net other (income) / expense
16
(9)
(27)
Earnings from continuing operations before income taxes
5,546
4,190
3,676
Provision for income taxes
1,178
921
746
Net earnings from continuing operations
4,368
3,269
2,930
Discontinued operations, net of tax
12
7
Net earnings
$
4,368 $
3,281 $
2,937
Basic earnings per share
Continuing operations
Discontinued operations
Net earnings per share
Diluted earnings per share
Continuing operations
Discontinued operations
$
8.72 $
6.39 $…
arrow_forward
Use the table for the question(s) below
Name
Gannet
New York Times
McClatchy
Media General 326
Lee Enterprises
Average
Maximum
Minimum
OA $6.52
OB $7.00
Market Enterprise
Capitalization Value
(5 million)
6350
2423
675
OC. $7.00
OD 17 24
267
1192
(5 million)
10,163
3472
3061
1724
14.89
Price/
Book
PIE
7.36
0.73
18.09 2.64
9.76 1.68
0.39
6.55 0.82
11.33
1.25
+60% 112%
-40% 69%
Enterprise
1.31
Valuel
Sales
1.4
1.10
1.40
1.57
1.35
+16%
-18%
Enterprise
7.65
Value/
EBITDA
The table above shows the stock prices and multiples for a number of firms in the newspaper publishing industry. Another newspaper publishing firm (not shown) had sales of $600 million, EBITDA
of $84 million, excess cash of $70 million, $11 milion of debt, and 120 million shares outstanding. If the average enterprise value to sales for comparable businesses is used, which of the following is
the best estimate of the firm's share price?
CIED
5.04
7.21
5.64
6.65
6.44
+22%
-19%
arrow_forward
Calculate return on assets and profit margin.LO9
The following information is available for Ware Ltd for 2018: sales revenue $7 840 000; cost of sales $3 528 000; profit $1 176 000; total equity $2 233 300; average total assets $5 113 000. Calculate the return on assets and profit margin for Ware Ltd for 2018.
arrow_forward
What is the MCIT of ABC Corporation?
P21,000
P42,000
P17,500
P16,000
arrow_forward
Waldo Lt Balance sheet
£m
£m
Non Current Assets
180
Current Assets
75
Current Liabilities
(25)
50
230
Financed by:
Ordinary Shares (25p)
138
Reserves
32
8% Loan notes
60
230
The realisable value of the fixed assets is estimated at £135m and the realisable value of current assets is estimated at £45m. Recent profit after tax is £37m and a sector P/E ratio is 12.
Using the information above, calculate the firm value per share using the realisable value method for the shares in Waldo Ltd.
Group of answer choices
£0.70 or 70p per share
£0.14 or 14p per share
£0.17 or 17p
£0.31 or 31p per share
arrow_forward
SEE MORE QUESTIONS
Recommended textbooks for you
Fundamentals of Financial Management (MindTap Cou...
Finance
ISBN:9781337395250
Author:Eugene F. Brigham, Joel F. Houston
Publisher:Cengage Learning
Related Questions
- B. Working Capital = Current Assets - Current Liabilities 2021 = Working Capital $263,000 - $50,000 $213,000 2022 Working Capital = $347,000 $69,000 = $278,000 Current Ratio = Current Assets Current Liabilities 2021 2022 Current Ratio = $263,000 $50,000 $347,000 $69,000 = 5.3:1 5.0:1 Debt to Total Assets = Total Liabilities Total Assets 2021 2022 = $180,000 $382,000 $184,000 $487,000 = 47.1% 37.8% C. The working capital has increased between 2021 and 2022, indicating greater liquidity for the firm in its ability to pay its current liabilities as they become due. The current ratio has decreased between 2021 and 2022; however, it is still quite high. Note also that there is a substantial portion of the current assets in cash and accounts receivable, which may be converted into cash quickly (assuming the receivables are collectible). The company, therefore, should not have any problems in paying its current liabilities as they become due. The debt to total assets indicates the percentage…arrow_forwardConsolidated Statements of Operations FINANCIAL STATEMENTS Table of Contents Index to Financial Statements (millions, except per share data) 2020 2019 2018 Sales Other revenue $ 92,400 $ 77,130 $ 74,433 1,161 982 923 Total revenue 93,561 78,112 75,356 Cost of sales 66,177 54,864 53,299 Selling, general and administrative expenses 18,615 16,233 15,723 Depreciation and amortization (exclusive of depreciation included in cost of sales) 2,230 2,357 2,224 Operating income 6,539 4,658 4,110 Net interest expense 977 477 461 Net other (income) / expense 16 (9) (27) Earnings from continuing operations before income taxes 5,546 4,190 3,676 Provision for income taxes 1,178 921 746 Net earnings from continuing operations 4,368 3,269 2,930 Discontinued operations, net of tax 12 7 Net earnings $ 4,368 $ 3,281 $ 2,937 Basic earnings per share Continuing operations Discontinued operations Net earnings per share Diluted earnings per share Continuing operations Discontinued operations $ 8.72 $ 6.39 $…arrow_forwardUse the table for the question(s) below Name Gannet New York Times McClatchy Media General 326 Lee Enterprises Average Maximum Minimum OA $6.52 OB $7.00 Market Enterprise Capitalization Value (5 million) 6350 2423 675 OC. $7.00 OD 17 24 267 1192 (5 million) 10,163 3472 3061 1724 14.89 Price/ Book PIE 7.36 0.73 18.09 2.64 9.76 1.68 0.39 6.55 0.82 11.33 1.25 +60% 112% -40% 69% Enterprise 1.31 Valuel Sales 1.4 1.10 1.40 1.57 1.35 +16% -18% Enterprise 7.65 Value/ EBITDA The table above shows the stock prices and multiples for a number of firms in the newspaper publishing industry. Another newspaper publishing firm (not shown) had sales of $600 million, EBITDA of $84 million, excess cash of $70 million, $11 milion of debt, and 120 million shares outstanding. If the average enterprise value to sales for comparable businesses is used, which of the following is the best estimate of the firm's share price? CIED 5.04 7.21 5.64 6.65 6.44 +22% -19%arrow_forward
- Calculate return on assets and profit margin.LO9 The following information is available for Ware Ltd for 2018: sales revenue $7 840 000; cost of sales $3 528 000; profit $1 176 000; total equity $2 233 300; average total assets $5 113 000. Calculate the return on assets and profit margin for Ware Ltd for 2018.arrow_forwardWhat is the MCIT of ABC Corporation? P21,000 P42,000 P17,500 P16,000arrow_forwardWaldo Lt Balance sheet £m £m Non Current Assets 180 Current Assets 75 Current Liabilities (25) 50 230 Financed by: Ordinary Shares (25p) 138 Reserves 32 8% Loan notes 60 230 The realisable value of the fixed assets is estimated at £135m and the realisable value of current assets is estimated at £45m. Recent profit after tax is £37m and a sector P/E ratio is 12. Using the information above, calculate the firm value per share using the realisable value method for the shares in Waldo Ltd. Group of answer choices £0.70 or 70p per share £0.14 or 14p per share £0.17 or 17p £0.31 or 31p per sharearrow_forward
arrow_back_ios
arrow_forward_ios
Recommended textbooks for you
- Fundamentals of Financial Management (MindTap Cou...FinanceISBN:9781337395250Author:Eugene F. Brigham, Joel F. HoustonPublisher:Cengage Learning
Fundamentals of Financial Management (MindTap Cou...
Finance
ISBN:9781337395250
Author:Eugene F. Brigham, Joel F. Houston
Publisher:Cengage Learning